Is IYH a good investment?

iShares U.S. Healthcare ETF (IYH) is a healthcare and biotech ETF. As of September 11, 2026, ETF Copilot scores IYH 5.3 out of 10 — highest on Growth (7.9), lowest on Return (3.2). It trades at 30.5 times earnings, against its own median of 25.1. Its ten largest holdings are 59% of the fund.

Updated September 11, 2026

How is IYH rated? ETF Copilot scores iShares U.S. Healthcare ETF (IYH) 5.3 out of 10

As of September 11, 2026, ETF Copilot scores iShares U.S. Healthcare ETF (IYH) 5.3 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

Overall: 5.3 / 10
Growth: 7.9 / 10
Valuation: 3.7 / 10
Risk: 7.2 / 10
Quality: 4.4 / 10
Return: 3.2 / 10

What is IYH's expense ratio? 0.37% a year

As of September 11, 2026, IYH charges 0.37% a year, yields 1.66% and holds $3.7B in assets across 102 positions.

iShares U.S. Healthcare ETF (IYH) — cost, income and size
Measure	IYH
Expense ratio	0.37%
Dividend yield	1.66%
Assets under management	$3.7B
Holdings	102

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

What stands out in IYH's data

Tracks U.S. healthcare sector stocks through a cap-weighted index.

Priced above its own history and most peers — you pay more for each dollar of earnings.

Its trailing EBITDA multiple of 18.6x sits above the category median of 15.9x and its own historical median of 15.6x. Top holdings concentration is 58.7%.

Provides a focused U.S. healthcare allocation for a portfolio already holding broad market exposure.

Why did IYH move this week? It fell 4.4% in the week to September 11, 2026 — Eli Lilly and Amgen drove it

IYH fell 4.4% in the week to September 11, 2026. The holdings that moved it most were Eli Lilly (−3.8%), Amgen (−15.0%) and Johnson & Johnson (−4.6%); Roivant Sciences (+18.6%) pushed the other way.

Is IYH expensive right now? It trades at 30.5 times earnings, against its own median of 25.1

As of September 11, 2026, IYH is more expensive than 88% of its own 114 monthly readings since 2017 — 100 of those months were cheaper than today.

Trailing twelve-month, computed by ETF Copilot from the fund's holdings rather than quoted from a data provider, and rebuilt nightly.

What's inside IYH?

What's inside IYH: Size (Large 88%, Mid 12%, Small 1%); Geography (International 3%, US 97%); AI 0.4%.

What are IYH's top holdings? The ten largest are 59% of the fund

Eli Lilly, Johnson & Johnson, Abbvie, Merck, UnitedHealth, Thermo Fisher Scientific, Amgen, Abbott Laboratories, Gilead Sciences and Pfizer are IYH's largest holdings, in that order.

More concentrated than 75% of Healthcare & Biotech ETFs.

Half of IYH's weight sits in its 7 largest positions, and once those weights are taken into account it behaves like 19 equally weighted holdings.

Cite this

ETF Copilot, “iShares U.S. Healthcare ETF (IYH) scores and holdings analysis”, as of September 11, 2026.
https://etf-copilot.com/etf/iyh